相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease
Annika Sommer et al.
CELL STEM CELL (2018)
Identification of a highly neurotoxic alpha-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease
Diego Grassi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A common antigenic motif recognized by naturally occurring human VH5-51/VL4-1 anti-tau antibodies with distinct functionalities
Adrian Apetri et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau
Jeroen van Ameijde et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
First-in-human assessment of PRX002, an anti--synuclein monoclonal antibody, in healthy volunteers
Dale B. Schenk et al.
MOVEMENT DISORDERS (2017)
T cells from patients with Parkinson's disease recognize α-synuclein peptides
David Sulzer et al.
NATURE (2017)
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Yvette C. Wong et al.
NATURE MEDICINE (2017)
Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy
Brian Spencer et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Immunological memory to hyperphosphorylated tau in asymptomatic individuals
Gabriel Pascual et al.
ACTA NEUROPATHOLOGICA (2017)
Active immunization therapies for Parkinson's disease and multiple system atrophy
Achim Schneeberger et al.
MOVEMENT DISORDERS (2016)
Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
Abid Oueslati
JOURNAL OF PARKINSONS DISEASE (2016)
Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease
Cassandra A. DeMarshall et al.
IMMUNOLOGY LETTERS (2015)
Inhibition of amyloid-β plaque formation by α-synuclein
Teresa Bachhuber et al.
NATURE MEDICINE (2015)
Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson's disease: an observational and case-control study
G. T. Kannarkat et al.
NPJ PARKINSONS DISEASE (2015)
Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
Dora Games et al.
JOURNAL OF NEUROSCIENCE (2014)
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson's Disease: Sources of (Error) Variance in Biomarker Assays
Sebastian Heinzel et al.
PLOS ONE (2014)
α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
Hien T. Tran et al.
CELL REPORTS (2014)
Epitope mapping of antibodies to alpha-synuclein in LRRK2 mutation carriers, idiopathic Parkinson disease patients, and healthy controls
Beatriz Alvarez-Castelao et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region
William T. Wissemann et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Jing L. Guo et al.
CELL (2013)
Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for Neurodegeneration
Katrin Beyer et al.
MOLECULAR NEUROBIOLOGY (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease
Daniela Besong-Agbo et al.
NEUROLOGY (2013)
Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer's Disease
Niklas K. U. Koehler et al.
PLOS ONE (2013)
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
Penelope G. Foulds et al.
SCIENTIFIC REPORTS (2013)
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Eun-Jin Bae et al.
JOURNAL OF NEUROSCIENCE (2012)
Correlation between Protective Immunity to α-Synuclein Aggregates, Oxidative Stress and Inflammation
Marina A. Gruden et al.
NEUROIMMUNOMODULATION (2012)
α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson's Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
Lynnae M. Smith et al.
PLOS ONE (2012)
Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression
Marina A. Gruden et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Lysosomal Storage Disorders and Parkinson's Disease: Gaucher Disease and Beyond
Tamar Shachar et al.
MOVEMENT DISORDERS (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Genome-Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Todd L. Edwards et al.
ANNALS OF HUMAN GENETICS (2010)
Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology
Ayse Ulusoy et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits α-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions
Katerina E. Paleologou et al.
JOURNAL OF NEUROSCIENCE (2010)
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Taye H. Hamza et al.
NATURE GENETICS (2010)
Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization
Joy Concepcion et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2009)
Invited Article: Nervous system pathology in sporadic Parkinson disease
Heiko Braak et al.
NEUROLOGY (2008)
Autoantibodies to alpha-synuclein in inherited Parkinson's disease
Katerina K. Papachroni et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
WX Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
